A lung cancer pill drastically cuts the risk of death after surgery
How It Works UK|Issue 179
A once-daily pill halved people’s risk of dying from a common lung cancer when they took the drug after tumour-removal surgery, new trial data shows
JENNIFER NALEWICKI
A lung cancer pill drastically cuts the risk of death after surgery

Made by the biopharmaceutical company AstraZeneca, Tagrisso, also known as osimertinib, reduced the five-year risk of death in lung cancer patients by 51 per cent. The study was the result of a 682-patient trial that included participants diagnosed with non-small cell lung cancer (NSCLC), one of two main types of primary lung cancer. All patients also had a mutation in the epidermal growth factor receptor (EGFR) gene, which codes for a protein found on the surfaces of cells. EGFR mutations can boost cancer’s ability to grow and spread, raising patients’ risk of cancer recurrence post-treatment.

Denne historien er fra Issue 179-utgaven av How It Works UK.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

Denne historien er fra Issue 179-utgaven av How It Works UK.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

FLERE HISTORIER FRA HOW IT WORKS UKSe alt
RESCUE IN SPACE
How It Works UK

RESCUE IN SPACE

Fortunately, space emergencies are a rare occurrence, but astronauts and space agencies need to be prepared for any eventuality that might arise

time-read
6 mins  |
Issue 194
NEANDERTHAL LIVING
How It Works UK

NEANDERTHAL LIVING

Why our prehistoric cousins were pioneers, not clueless apes

time-read
3 mins  |
Issue 194
BUILDING ONE WORLD TRADE CENTER
How It Works UK

BUILDING ONE WORLD TRADE CENTER

One World Trade Center rose from the ashes of the Twin Towers. Now, as the tallest building in New York City, it looks to the skies and the future. Here's how this sustainable and secure record-breaker was built

time-read
2 mins  |
Issue 194
BECOME A SMARTPHONE SCIENTIST
How It Works UK

BECOME A SMARTPHONE SCIENTIST

Amazing tips and tricks to transform your smartphone into a bug-finding, star-spotting, data-gathering device

time-read
2 mins  |
Issue 194
LIFTING THE LID ON ANTARCTICA
How It Works UK

LIFTING THE LID ON ANTARCTICA

What was the coldest continent like without ice?

time-read
3 mins  |
Issue 194
URBAN WILDLIFE
How It Works UK

URBAN WILDLIFE

How wild animals have evolved to thrive alongside humans in towns and cities

time-read
3 mins  |
Issue 194
WHAT IS SUNBURN?
How It Works UK

WHAT IS SUNBURN?

How solar rays can leave us red, sore and irritated

time-read
2 mins  |
Issue 194
ALL ABOUT FAT
How It Works UK

ALL ABOUT FAT

Fat is a complex, active organ. Here's how genetics, evolution, lifestyle and diet dictate how much we have beneath our skin

time-read
8 mins  |
Issue 194
The Space Force is launching lasers into orbit
How It Works UK

The Space Force is launching lasers into orbit

The Space Force aims to better pinpoint the location of Earth's true centre using lasers on GPS satellites, slated to launch in 2025. A set of Laser Retroreflector Arrays, or LRAS, will be installed onto two GPS III satellites, SV9 and SV10, as part of NASA's Space Geodesy Program. The lasers are designed to make precise sub-centimetre measurements using a technique called Satellite Laser Ranging, which will allow researchers to more accurately determine Earth's centre.

time-read
1 min  |
Issue 194
Eating too much sugar may accelerate cellular ageing
How It Works UK

Eating too much sugar may accelerate cellular ageing

A nutrient-rich diet with few added sugars may slow the rate of biological ageing in women. Scientists found that middle-aged women who ate more foods packed with vitamins, minerals and antioxidants had 'younger looking' cells than those who consumed less nutrient-rich diets.

time-read
2 mins  |
Issue 194